FILGRASTIM Teva 48 mio U/0.8ml ser prê 0.8 ml
7680607220044
CH-60722
L03AA02
06.07.3.
Reimbursement limitations:
FILGRASTIM
Administration au cours des chimiothérapies fortement myélotoxiques permettant d'espérer une évolution positive chez les patients …
1 / 3
google
Details
- Product number
- 6072202
- CPT
- -
- Packaging group
- 1
- Unit
- Spritze(n)
- Composition
- filgrastimum 48 Mio. U., acidum aceticum glaciale, polysorbatum 80, natrii hydroxidum, sorbitolum 40.0 mg, aqua ad iniectabile q.s. ad solutionem pro 0.8 ml corresp. natrium 0.042 mg.
Articles (1)
Filgrastim-Teva 48 / 0.8 ml, Injektionslösung in Fertigspritzen
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
- | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
40.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.042 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 106.40
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2010
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 60722
- Drug name
- Filgrastim-Teva, Injektionslösung in Fertigspritzen
- Galenic form
- INLFS
- ATC Code
- L03AA02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 08/01/2010
- Authorization expiration date
- 31/12/9999
- IT number
- 06.07.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- FILGRASTIM Teva 48 mio U/0.8ml ser prê 0.8 ml
- Description (DE)
- FILGRASTIM Teva 48 Mio E/0.8ml Fertspr 0.8 ml
- Market launch
- 08/01/2010
- Narcotic (BTM)
- No